Prostaglandin E2and the Pathogenesis of Pulmonary Fibrosis
- 1 September 2011
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 45 (3), 445-452
- https://doi.org/10.1165/rcmb.2011-0025rt
Abstract
Prostaglandin (PG)E(2) is a bioactive eicosanoid that regulates many biologically important processes in part due to its ability to signal through four distinct G-protein-coupled receptors with differential signaling activity and unique expression patterns in different cell types. Although PGE(2) has been linked to malignancy in many organs, it is believed to play a beneficial role in the setting of fibrotic lung disease. This is in part due to the ability of PGE(2) to limit many of the pathobiologic features of lung fibroblasts and myofibroblasts, including the ability of PGE(2) to limit fibroblast proliferation, migration, collagen secretion, and, as originally reported in the Journal by us in 2003, the ability to limit transforming growth factor (TGF)-β-induced myofibroblast differentiation. In the setting of lung fibrosis, PGE(2) production and signaling is often diminished. In the last 8 years, significant advances have been made to better understand the dysregulation of PGE(2) production and signaling in the setting of lung fibrosis. We also have a clearer picture of how PGE(2) inhibits myofibroblast differentiation and the receptor signaling pathways that can influence fibroblast proliferation. This review highlights these recent advances and offers new insights into the potential ways that PGE(2) and its downstream signals can be regulated for therapeutic benefit in a disease that has no validated treatment options.Keywords
This publication has 105 references indexed in Scilit:
- Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptorProstaglandins, Leukotrienes & Essential Fatty Acids, 2011
- Diminished Prostaglandin E2Contributes to the Apoptosis Paradox in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Latent Herpesvirus Infection Augments Experimental Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Phosphatase and Tensin Homologue on Chromosome 10 (PTEN) Directs Prostaglandin E2-mediated Fibroblast Responses via Regulation of E Prostanoid 2 Receptor ExpressionPublished by Elsevier BV ,2009
- Prostaglandin E2induces fibroblast apoptosis by modulating multiple survival pathwaysThe FASEB Journal, 2009
- Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary FibrosisMolecular and Cellular Biology, 2009
- Prostaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1American Journal of Respiratory Cell and Molecular Biology, 2008
- Cyclic AMPAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- PGE2inhibition of TGF-β1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signalingAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Plasminogen-Mediated Activation and Release of Hepatocyte Growth Factor from Extracellular MatrixAmerican Journal of Respiratory Cell and Molecular Biology, 2006